Bloomage BioTechnology Corporation Limited (SHA: 688363)
China
· Delayed Price · Currency is CNY 48.72
-0.48 (-0.98%)
Sep 6, 2024, 3:00 PM CST
Bloomage BioTechnology Corporation Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 5,802 | 6,075 | 6,359 | 4,947 | 2,632 | 1,885 | Upgrade
|
| Other Revenue | 8.71 | 0.6 | 0.41 | 0.55 | 1.05 | 1 | Upgrade
|
| Revenue | 5,811 | 6,076 | 6,359 | 4,948 | 2,633 | 1,886 | Upgrade
|
| Revenue Growth (YoY) | -10.59% | -4.45% | 28.53% | 87.93% | 39.63% | 49.28% | Upgrade
|
| Cost of Revenue | 1,590 | 1,659 | 1,482 | 1,118 | 510.98 | 389.74 | Upgrade
|
| Gross Profit | 4,221 | 4,417 | 4,877 | 3,829 | 2,122 | 1,496 | Upgrade
|
| Selling, General & Admin | 3,131 | 3,331 | 3,439 | 2,736 | 1,256 | 701.13 | Upgrade
|
| Research & Development | 460.17 | 446.35 | 388.19 | 284.34 | 141.16 | 93.89 | Upgrade
|
| Other Operating Expenses | 141.45 | 62.01 | 73.25 | 56.95 | 30.45 | 22.61 | Upgrade
|
| Operating Expenses | 3,756 | 3,847 | 3,915 | 3,083 | 1,452 | 826.79 | Upgrade
|
| Operating Income | 465.09 | 570.18 | 961.48 | 746.46 | 670.05 | 669.03 | Upgrade
|
| Interest Expense | -8.27 | -10.74 | -14.52 | -11.08 | - | -1.63 | Upgrade
|
| Interest & Investment Income | 26.88 | 39.78 | 50.44 | 45.07 | 52.19 | 9.06 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.36 | 3.9 | 25.19 | -12.05 | -16.99 | 5.9 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.44 | 1.71 | -3.88 | -2.62 | -0.77 | -2.1 | Upgrade
|
| EBT Excluding Unusual Items | 478.89 | 604.84 | 1,019 | 765.77 | 704.49 | 680.27 | Upgrade
|
| Gain (Loss) on Sale of Investments | -22.03 | -18.74 | -0.14 | 7.39 | 3.34 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -3.42 | -3.42 | -0.24 | 0.04 | 0.05 | 0.03 | Upgrade
|
| Asset Writedown | -1.87 | -1.87 | -0.53 | -3.91 | -0.34 | -1.31 | Upgrade
|
| Other Unusual Items | 150.94 | 120.91 | 118.32 | 120.9 | 51.36 | 22.1 | Upgrade
|
| Pretax Income | 602.5 | 701.72 | 1,136 | 890.2 | 758.9 | 701.09 | Upgrade
|
| Income Tax Expense | 100.82 | 118.98 | 174.73 | 114.64 | 113.89 | 116.48 | Upgrade
|
| Earnings From Continuing Operations | 501.68 | 582.74 | 961.38 | 775.56 | 645.01 | 584.61 | Upgrade
|
| Minority Interest in Earnings | 8.03 | 9.81 | 9.54 | 6.78 | 0.83 | 0.99 | Upgrade
|
| Net Income | 509.71 | 592.56 | 970.92 | 782.33 | 645.84 | 585.61 | Upgrade
|
| Net Income to Common | 509.71 | 592.56 | 970.92 | 782.33 | 645.84 | 585.61 | Upgrade
|
| Net Income Growth | -44.73% | -38.97% | 24.11% | 21.13% | 10.29% | 38.16% | Upgrade
|
| Shares Outstanding (Basic) | 481 | 482 | 481 | 480 | 478 | 437 | Upgrade
|
| Shares Outstanding (Diluted) | 481 | 482 | 483 | 483 | 478 | 437 | Upgrade
|
| Shares Change (YoY) | -0.35% | -0.27% | 0.03% | 0.95% | 9.47% | 1.53% | Upgrade
|
| EPS (Basic) | 1.06 | 1.23 | 2.02 | 1.63 | 1.35 | 1.34 | Upgrade
|
| EPS (Diluted) | 1.06 | 1.23 | 2.01 | 1.62 | 1.35 | 1.34 | Upgrade
|
| EPS Growth | -44.54% | -38.81% | 24.07% | 20.00% | 0.75% | 36.08% | Upgrade
|
| Free Cash Flow | -145.09 | -330.68 | -61.22 | 491.85 | -57.65 | -85.34 | Upgrade
|
| Free Cash Flow Per Share | -0.30 | -0.69 | -0.13 | 1.02 | -0.12 | -0.20 | Upgrade
|
| Dividend Per Share | 0.380 | 0.380 | 0.610 | 0.490 | 0.410 | 0.370 | Upgrade
|
| Dividend Growth | -37.70% | -37.70% | 24.49% | 19.51% | 10.81% | - | Upgrade
|
| Gross Margin | 72.64% | 72.69% | 76.69% | 77.40% | 80.59% | 79.33% | Upgrade
|
| Operating Margin | 8.00% | 9.38% | 15.12% | 15.09% | 25.45% | 35.48% | Upgrade
|
| Profit Margin | 8.77% | 9.75% | 15.27% | 15.81% | 24.53% | 31.06% | Upgrade
|
| Free Cash Flow Margin | -2.50% | -5.44% | -0.96% | 9.94% | -2.19% | -4.53% | Upgrade
|
| EBITDA | 682.44 | 771.58 | 1,124 | 866.92 | 740.23 | 729.43 | Upgrade
|
| EBITDA Margin | 11.74% | 12.70% | 17.68% | 17.52% | 28.12% | 38.69% | Upgrade
|
| D&A For EBITDA | 217.35 | 201.4 | 162.69 | 120.46 | 70.19 | 60.4 | Upgrade
|
| EBIT | 465.09 | 570.18 | 961.48 | 746.46 | 670.05 | 669.03 | Upgrade
|
| EBIT Margin | 8.00% | 9.38% | 15.12% | 15.09% | 25.45% | 35.48% | Upgrade
|
| Effective Tax Rate | 16.73% | 16.96% | 15.38% | 12.88% | 15.01% | 16.61% | Upgrade
|
| Revenue as Reported | 5,811 | 6,076 | 6,359 | 4,948 | 2,633 | - | Upgrade
|
| Advertising Expenses | - | 1,790 | 2,051 | 1,583 | 618.8 | 195.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.